Vivo Capital, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Vivo Capital, LLC held in its portfolio 47 assets valued at $1,547,066,991 (i.e. $1.55B).

The most valuable assets in the portfolio included: Terns Pharmaceuticals Inc ($216.02M), Cidara Therapeutics, Inc. ($211.32M), and Praxis Precision Medicines ($96.94M).

The chart below shows the top 10 valuable assets, and the table below shows the top 47 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in Vivo Capital, LLC Portfolio
Terns Pharmaceuticals Inc
Cidara Therapeutics, Inc.
Praxis Precision Medicines
Cogent Biosciences Inc
Trevi Therapeutics Inc
Avadel Pharmaceuticals PLC
Compass Therapeutics Inc
Dyne Therapeutics Inc
Abivax SA - ADR
DBV Technologies SA
Vivo Capital, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
Terns Pharmaceuticals Inc 5346928 216015891 Common
Cidara Therapeutics, Inc. 956670 211318836 Common
Praxis Precision Medicines 328895 96938512 Common
Cogent Biosciences Inc 2398993 85212231 Common
Trevi Therapeutics Inc 5094668 63785243 Common
Avadel Pharmaceuticals PLC 2684109 57842549 ADR
Compass Therapeutics Inc 9545466 51259152 Common
Dyne Therapeutics Inc 2614960 51148618 Common
Abivax SA - ADR 359305 48454076 SPONSORED ADS
DBV Technologies SA 2461626 47189370 SPONSORED ADS
SAB Biotherapeutics Inc 11420000 42710800 Common
Soleno Therapeutics Inc 894909 41434287 Common
Bright Minds Biosciences Inc 501617 39146191 Common
Sinovac Biotech Ltd. 5903000 38192410 SHS
Geron Corp 27225292 35937385 Common
Erasca Inc 9273428 34497152 Common
Zenas Biopharma Inc 853495 30990403 Common
Viridian Therapeutics Inc 982576 30577765 Common
Aclaris Therapeutics, Inc. 8888888 26755553 Common
CAMP4 Therapeutics Inc 4246568 26031462 Common
Tango Therapeutics Inc 2154780 19091351 Common
Alto Neuroscience Inc 1035551 18432808 Common
LB Pharmaceuticals Inc 800000 17808000 Common
Minerva Neurosciences Inc 4322747 17377443 Common
Oric Pharmaceuticals Inc 2118384 17328381 Common
Corvus Pharmaceuticals Holdings 2234566 17206158 Common
Olema Pharmaceuticals Inc 671843 16796075 Common
Pepgen Inc 2325000 15135750 Common
Design Therapeutics Inc 1612903 15129030 Common
Dianthus Therapeutics Inc 353998 14588258 Common
Moonlake Immunotherapeutics 1000000 13180000 Common
Cytomx Therapeutics Inc 2884615 12288460 Common
Unicycive Therapeutics 1789916 10327815 Common
Eupraxia Pharmaceuticals Inc 1350000 10192500 Common
Abeona Therapeutics, Inc. 1842751 9711298 Common
Verastem Inc 1106524 8542365 Common
Silence Therapeutics PLC 1105454 6721160 ADS
Monopar Therapeutics Inc 90500 5909650 Common
Surrozen Inc 260000 5876000 Common
Palisade Bio Inc 2293578 5389908 Common
Sera Prognostics Inc 1650440 4868798 Common
Instil Bio Inc 292743 3220173 Common
Pasithea Therapeutics Corp 2100000 2709000 Common
Tenax Therapeutics Inc 208333 2539579 Common
EnGene Holdings Inc 285046 843736 Warrants
Bolt Therapeutics Inc 72414 395960 Common
Precision Biosciences Inc 4675 19449 Common